Full Text
PMU101 MOST BOTHERSOME SYMPTOM MEASUREMENT STRATEGIES: CONSIDERATIONS FOR REGULATED CLINICAL TRIALS

Abstract

Authors

I. Mazar S. Ollis S. Li A. Yaworsky C. Gwaltney

Back to Volume 22, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×